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Abstract 
Introduction: The present study was aimed at investigating the effectiveness of cognitive-behavioral 
group therapy in quality of life and hope among patients with multiple sclerosis (MS).  
Materials and Methods: In this clinical trial, using a quasi-experimental pretest-posttest control 
group design, 20 MS patients were selected through available sampling among the patients in 
Mashhad Multiple Sclerosis Association in 2016 and were randomly assigned into two experimental 
and control groups, each containing 10 subjects. The experimental group underwent cognitive-
behavioral group therapy in 10 weekly sessions of 2 hours and the control group did not receive this 
treatment. In the pretest and posttest, Quality of Life Questionnaire-Short Form (SF-36) and 
Snyder  Adult Hope Scale (AHS) were implemented on all the subjects of the experimental and control 
groups. Data was analyzed using analysis of covariance and t-test. 
Results: The results demonstrated that cognitive-behavioral group therapy significantly leads to 
increased overall index of quality of life and hope (p<0.001) in the experimental group compared to 
the control group. Further, out of quality of life components, dimensions of physical function, role 
limitation due to physical problems, fatigue or vitality, emotional health and general health of the 
experimental group showed a greater increase at the end of the intervention relative to the control 
group (p<0.001) and concerning other subscales, the difference between the two groups was not 
significant.  
Conclusion: Cognitive-behavioral group therapy results in enhanced quality of life and hope in 
patients with multiple sclerosis. 
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Introduction 
Multiple sclerosis (MS) is developed in the 
central nervous system (CNS) due to the 
inflammation and degeneration of the nerve 
myelin sheath and is largely prevalent among 
people aged 18 to 45 years and affects the 
patient's individual and social performance. In 
2006, American National Multiple Sclerosis 
Society (NMSS) estimated MS prevalence 
around 400,000 people in the United States 
and over 2 million people worldwide [3]. 
According to Iranian Multiple Sclerosis 
Society in 2013, there are about 70,000 
patients with MS [4]. Chiaravalloti and Deluca 
[5] found that psychological problems are the 
main cause of disabilities, social damages and 
low quality of life in MS patients.  
The optimal quality of life does not mean the 
absence of disease but indicates feeling good 
in a variety of psychological, social, functional 
and mental fields [6]. Health-related quality of 
life includes the value that the individual 
attaches to his life despite the effect of illness, 
injury or treatment on his actions, perceptions 
and social opportunities. 
Results of the research by Rausak et al. [8] 
indicated that MS patients’ quality of life, 
especially in older people with a secondary 
progressive course of the disease, is 
significantly low. MS patients significantly 
have lower quality of life compared to 
general  population and people with other 
chronic diseases [10].  The quality of life and 
components of optimism and self-efficacy are 
among the variables affecting the perception 
of disease in patients with MS [11]. Results of 
a study [12] suggested that there is a 
significant correlation between health 
behaviors such as nutrition, stress 
management, physical activity, positive 
interpersonal relationships and spiritual 
growth with quality of life. 
One of the important concepts in the context 
of quality of life and the positive 
psychological approach is the concept of 
hopefulness. Hope is defined as the “ability to 
design passages to target goals in spite of the 
existing barriers and agency or the necessary 
motive for using these passages” [13]. Hope 
can facilitate the coping process [14, 15], 
increase improvement [16, 17] and enhance 
the quality of life and treatment of patients 
[18]. In the study by Sho’a’ Kazemi and 
Mo’meni Javid [19], it was demonstrated that 
there is a significant positive relationship 
between quality of life and life expectancy 
among female cancer patients. Results of the 
research conducted by Snyder and Anderson 
[20] revealed that enhanced hope is effective 
in improving the quality of life and promoting 
the self-care level and general health of 
patients with chronic physical disorders. 
Rasouli et al. [21] carried out a study on 24 
MS patients and indicated that hope therapy 
simultaneously improves hopefulness and 
quality of life of these patients. 
After being aware of their diagnosis, MS 
patients may lose their hope and ability to 
adapt to the conditions of their disease due to 
the debilitating symptoms of the disease and 
this factor causes them not to pay sufficient 
attention to their treatment and not take the 
doctors’ instructions seriously. They do not 
make much effort to improve their health 
condition and thereby worsen their health 
status [22].  
Through challenging negative automatic 
thoughts and identifying and correcting the 
individual’s cognitive errors, cognitive-
behavioral therapy provides an opportunity for 
the patient to accept his disease and face it 
reasonably. Further, by changing the 
cognitions and modifying the irrational beliefs 
of the individual, his attitude to self, world and 
future is transformed and subsequently, the 
patient can adopt a new and flexible 
perspective instead of focus on disabilities and 
hopelessness about the future [23]. Several 
studies have shown the effectiveness of 
cognitive-behavioral group therapy in reduced 
psychological distress and symptoms of 
depression and anxiety in chronic medical 
disorders, including diabetes (24), chronic pain 
(25), AIDS (26), heart disease (27) and 
hepatitis B (28). This treatment effectively 
decreases the symptoms of insomnia, fatigue, 
stress, anxiety and depression of most MS 
patients (29-32). Casio et al. [33] showed the 
effectiveness of cognitive-behavioral therapy 
in improved symptoms of depression and 
quality of life among 127 MS patients. In the 
study by Van Cassel et al. [34], the results 
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therapy compared to relaxation therapy (RT) 
suggested that cognitive-behavioral therapy 
leads to a more significant improvement in 
fatigue, depression, anxiety and stress of MS 
patients. 
Regardless of how much MS treatment is 
effective for the patient, patients, their families 
and experts agree on this point that living with 
this disease is very difficult and disappointing 
in physical and mental terms [35]. Such a 
process can have adverse consequences in 
various individual, family, social and 
occupational aspects of the patient. Thus, 
given the impact of psychological factors on 
chronic diseases and the role of chronic 
diseases such as MS in exacerbating 
psychological problems and considering the 
effectiveness of cognitive-behavioral 
interventions in patients with various chronic 
diseases, it seems that cognitive-behavioral 
group therapy can improve the quality of life 
and increase hopefulness in MS patients. 
Therefore, the present study aims to 
investigate the effectiveness of cognitive-
behavioral group therapy in promoting the 
quality of life and hopefulness of patients with 
multiple sclerosis. 
Materials and Methods 
The present research was a quasi-experimental 
study with a pretest-posttest control group 
design, which lasted from September to 
November 2016. Of the research statistical 
population including all MS patients with a 
file in Mashhad Multiple Sclerosis Society, 20 
patients with inclusion criteria were selected 
using purposive and available sampling 
method and were randomly assigned into two 
experimental and control groups. The 
inclusion criteria were as follows: Age 
between 20 and 50 years, having a minimum 
degree of diploma and written consent for 
participation in the research. The exclusion 
criteria included the following: Being in the 
acute phase of the disease so that there is no 
physical ability to attend the sessions, heart or 
brain attack, severe depression and drug 
addiction and existence of other neurological 
disorders such as epilepsy. Before 
implementing the intervention process, a 
meeting was held with members of the two 
groups in which the goals of the plan were 
explained to all patients and the necessary 
assurance was given to them about the 
confidentiality of information as well as the 
possibility of discontinuation of treatment 
whenever the patient wishes so. The sessions 
were held once a week (2 hours) over 2 
months and a half for the subjects of the 
experimental group, and the control group was 
only asked to attend the pretest and posttest 
and remain on the waiting list to receive 
treatment. The content of cognitive-behavioral 
group therapy sessions [36] is presented in 
table 1. 
Research tools 
Quality of Life Questionnaire-Short Form 
(SF-36) 
This questionnaire is a general tool for 
measuring health status and quality of life 
which can be applied to evaluate health status 
and quality of life associated with the health of 
normal and patient population groups. This 
questionnaire consists of 36 items in 8 
dimensions of health including physical 
function (10 items), role limitation due to 
physical problems (4 items), role limitation 
due to emotional problems (3 items), fatigue 
or vitality (4 items), emotional health (5 
items), social function (2 items), physical pain 
(2 items) and general health (5 items). 
Question number 2 does not belong to any 
dimension and is added to the total score. The 
way to score is determined by the number of 
options for each item. A score between zero 
(worst condition) and 100 (best condition) is 
assigned to each item. The total score of the 
questionnaire varies from 0 to 100 and the 
higher the score, the better the quality of life 
will be [37]. 
The internal consistency of the eight subscales 
of the questionnaire has been reported to be 
between 0.67 and 0.94 through Cronbach's 
alpha [38]. Validity and reliability of the 
Persian version of this questionnaire have been 
reviewed by Montazeri et al. [39]. In their 
research, reliability test of the questionnaire 
using the statistical analysis of "internal 
consistency" showed that except for the 
vitality scale (a=0.65), other scales enjoy 
minimum standard reliability coefficients 
within the range of 0.77 to 0.9. The statistical 




This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0). 
Downloaded from: www.jemerg.com	
H. Shareh et al.  
demonstrated that the Persian version of SF-36 
is able to distinguish demographic subgroups 
by gender and age. 
Adult Hope Scale (AHS) 
This self-assessment questionnaire developed 
by Snyder et al. in 1991 for the measurement 
of hope includes twelve 8-option questions 
(from totally agree to totally disagree). The 
test scores range between 8 and 64. Score 8 
indicates the lowest level of hope and score 64 
represents the highest level of hope. 
Cronbach's alpha of the test ranged from 0.74 
to 0.84 in 6 samples from college graduates 
and 2 samples from individuals under 
psychological treatment. Test-retest coefficient 
of the questionnaire is 0.80 and in courses of 
more than 10 weeks, it is higher than this 
amount [40]. Coordination of questions in this 
scale with Snyder’s hope theory suggests its 
good content validity. Correlation of this 
questionnaire with Beck Hopelessness Scale is 
-0.51 and its correlation with Beck Depression 
Inventory is -0.42, which indicate the 
concurrent validity of this questionnaire [41]. 
In the study performed by Ghobari et al. [42] 
on student population of Iran, reliability of this 
test was calculated to be 0.82 using Cronbach's 
alpha. In another study conducted by Kermani 
et al. [43] on 371 students in Tehran, 
Cronbach's alpha coefficient was obtained to 
be 0.86. In Khalaji’s [44] research, reliability 
of this scale was 0.70 through Cronbach's 
alpha and 0.74 using test-retest after one 
month. 
For data analysis, independent group t-test and 
one-way analysis of covariance (ANCOVA) 
were used in SPSS-22. 
Table 1: Content of cognitive-behavioral group therapy sessions 
Introductory session: Preparing and determining group structure, defining goals, discovering 
expectations, creating group cohesion and coping with the initial anxiety of group members. 
First session: Introducing the cognitive-behavioral approach to emotional disorders particularly 
depression and anxiety, describing the biopsychosocial model of emotional disorders, eliminating 
resistance to treatment. Home assignment: Completing the sheets for the biopsychosocial model. 
Second session: Reviewing the previous session’s assignment, teaching the relationship between 
activities and mood states including sadness and feeling of hopelessness, using behavioral 
interventions to modify behaviors for improving the mood, providing feedback and reinforcement to 
group members, facilitating interactions within the group. Home assignment: Completing the activity 
program and mood rating. 
Third session: Reviewing the previous session’s assignment, examining the outcomes and 
consequences of behavioral modifications, determining “mood changes” targeted by cognitive 
interventions, naming and rating the emotions experienced in the existing tough situations by 
examples. Home assignment: Completing the first two columns of the thought record sheet (situations 
and emotions). 
Fourth session: Reviewing the previous session’s assignment, describing and interpreting “self-talk” 
as a relationship between the situation and the emotion by the patient’s examples, examining 
automatic thoughts and focusing on the thoughts that have the greatest relationship with emotion, 
introducing a technique for providing evidence, identifying and evaluating the existing evidence about 
automatic thoughts. Home assignment: Completing the first four columns of the thought record sheet. 
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the patient’s questions and examples, introducing a list of “intellectual distortions” along with 
examples. Home assignment: Completing the first seven columns of the thought record sheet and 
determining intellectual distortions. 
Sixth session: Reviewing the previous session’s assignment, introducing alternative thoughts, 
applying problem-solving about alternative thoughts. Home assignment: Completing thought record 
sheets. 
Seventh session: Reviewing the previous session’s assignment, bringing up behavioral experiments, 
designing an experiment consistent with the patient’s example or case, teaching the imaginal exposure 
technique to reduce anxiety from social situations and thus increase quality of life. Home assignment: 
Doing a test and reviewing its results and consequences. 
Eighth session: Reviewing the previous session’s assignment, introducing deep cognitions, the 
concept of conditional assumptions and core and important beliefs, using downward arrow technique. 
Home assignment: Doing the downward arrow exercise. 
Ninth session: Reviewing the previous session’s assignment, explaining the relationship between 
conditional assumptions and core beliefs through spectrum model, introducing the coping strategies 
related to core beliefs, training problem-solving. Home assignment: Applying alternative coping 
strategies and monitoring its outcomes. 
Tenth session: Reviewing the previous session’s assignment, strengthening changes, discussing the 




20 MS patients participated in the present 
study. In the experimental group, there were 7 
male patients and 3 female patients and in the 
control group, 6 male patients and 4 female 
patients were present. Table (2) displays 
descriptive indicators of age and data from 
implementing SF-36 and AHS questionnaires 
in the pretest and posttest for each of the 
experimental and control groups.
Table 2: Mean and SD of the research variables in the pretest and posttest for both groups 
Variables Groups Pretest Posttest 
  Mean SD Mean SD 
Age Experimental 33.52 5.21   
Control 34.9 6.08   
Physical function Experimental 61.55 23.16 69.95 29.44 
Control 62.66 27.43 60.35 24.3 
Role limitation due to 
physical problems  
Experimental 41.8 30.19 51.26 33.1 
Control 41.7 28.37 43.64 24.78 
Role limitation due to 
emotional problems  
Experimental 61.99 29.49 63.9 27.4 
Control 60.35 29.33 61.34 26.7 
Fatigue or vitality  Experimental 59.07 28.87 71.3 29.61 
Control 60.34 30.76 60.67 28.78 
Emotional health Experimental 55.05 26.67 64.55 29.5 
Control 57 28.3 57.67 28.76 
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Control 65.95 28.6 66.2 27.67 
Physical pain Experimental 47.17 20.2 48.42 21.18 
Control 48.41 19.37 46.7 18.78 
General health Experimental 60.87 22.39 71.34 24.5 
Control 58.35 23.1 60.85 21.41 
Overall quality of life Experimental 56.8 29.67 63.33 30.5 
Control 56.84 28.3 57.18 29.55 
Hope Experimental 20.3 6.58 24 5.88 
Control 19.3 5.5 19.9 4.18 
 In Table (3), results of t-test to compare pretests and homogeneity of variances test and regression 
slope as presumptions of doing the analysis of covariance have been provide. 
Table 3: Comparison of means in the baseline and analysis of covariance assumptions 
 Comparison of 
means in the pretest 
Homogeneity of 
variances assumption 
Homogeneity of regression 
slopes assumption 




F Significance level 
Physical function 1.45 0.164 0.98 0.33 3.5 0.072 
Role limitation due 
to physical 
problems 
0.19 0.85 0.11 0.74 3.2 0.084 
Role limitation due 
to emotional 
problems 
1.78 0.112 0.33 0.57 3.11 0.078 
Fatigue or vitality 1.33 0.176 1.21 0.141 2.25 0.168 
Emotional health 1.74 0.116 1.39 0.119 2.84 0.123 
Social function 1.19 0.211 1.1 0.178 3.36 0.073 
Physical pain 1.08 0.263 0.57 0.412 0.87 0.357 
General health 1.68 0.127 1.88 0.073 2.90 0.116 
Overall quality of 
life 
0.35 0.731 0.82 0.372 0.84 0.368 
Hope 0.85 0.406 0.09 0.765 3.4 0.076 
 
Results of table (3) indicate that the two 
groups are similar in the pretest and 
homogeneity of variances and homogeneity of 
regression slope assumptions are established. 
Thus, ANCOVA was employed to measure the 
effectiveness of cognitive-behavioral group 
therapy in MS patients’ quality of life and 
hope. Analysis of covariance results to 
compare the experimental and control groups 
in the research variables after removing the 







Table 4: Summary of the results of the analysis of covariance test to investigate the impact of 
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Physical function 1385.25 1 1387.25 4.47 0.048 0.21 
Role limitation due to 
physical problems 
5317.87 1 5317.87 5.13 0.037 0.23 
Role limitation due to 
emotional problems 
2634.3 1 2634.3 3.82 0.067 0.18 
Fatigue or vitality 1490.76 1 1490.76 4.44 0.049 0.20 
Emotional health 840.03 1 840.03 5.92 0.026 0.26 
Social function 4.98 1 4.98 0.01 0.928 0.00 
Physical pain 1.52 1 1.52 0.01 0.944 0.00 
General health 1874.6 1 1874.6 10.33 0.005 0.38 
Overall quality of life 9905.14 1 9905.14 35.8 0.001 0.68 
Hope 61.4 1 61.4 11.28 0.004 0.53 
 
Analysis of covariance results suggest that 
cognitive-behavioral group therapy leads to 
increased hope and improved overall quality 
of life in the dimensions of physical function, 
role limitation due to physical problems, 
fatigue or vitality, emotional health and 
general health of MS patients. However, 
comparison of the two groups in the 
dimensions of role limitation due to emotional 
problems, social function and physical pain is 
not significant. Additionally, the effect size 
about overall quality of life and hope is greater 
than other cases. 
The following diagrams visually show changes 
in the scores of the research variables for the 
experimental and control groups. Accordingly, 
it can be observed that in the experimental 
group compared to the control group, the 
changes in the posttest scores are greater than 
the pretest scores. 
 
Chart 1: Mean pretest and posttest scores of hope and quality of life dimensions of the subjects 
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Chart 2: Mean pretest and posttest scores of hope and quality of life dimensions of the subjects 
in the control group 
Discussion 
This study was aimed at investigating the 
effectiveness of cognitive-behavioral group 
therapy in quality of life and hopefulness of 
MS patients. The research results 
demonstrated that after attending cognitive-
behavioral group therapy sessions, the overall 
quality of life and hope increased. Dimensions 
of physical function, role limitation due to 
physical problems, fatigue or vitality, 
emotional health, general health and quality of 
life of patients with multiple sclerosis 
improved. However, no improvement was 
observed in the dimensions of role limitation 
due to emotional problems, social function and 
physical pain. These findings are relatively 
consistent with the results of other studies 
performed on the effectiveness of the 
cognitive-behavioral group therapy in MS 
disease [50].  
In a randomized and controlled clinical trial, 
Gerasino et al. [46] evaluated the effectiveness 
of cognitive-behavioral group therapy in 82 
MS patients and concluded that the 
experimental group relative to the control 
group had a significant improvement in quality 
of life, psychological well-being and self-
efficacy. This result persisted for up to 6 
months after treatment. In another study on 37 
MS females, Sinclair and Scrougi [47] found 
that cognitive-behavioral interventions 
significantly improve the quality of life and 
mental health of patients. In explaining the 
results of the present research, it can be stated 
that teaching the main components of 
cognitive-behavioral therapy, such as 
replacing thoughts with rational beliefs, 
visualization, exposure and cognitive 
restructuring, can reduce anxiety and 
depression and ultimately improve the quality 
of life in MS patients. 
In this study, cognitive-behavioral group 
therapy did not have any significant effect on 
role limitation due to emotional problems, 
social function and physical pain in MS 
patients. Results of this research are consistent 
with the findings of some of the previous 
studies and incongruent with some other. The 
obtained results concerning the effectiveness 
of cognitive-behavioral therapy in depression 
of MS patients reveal that this treatment makes 
no impact on physical complaints and 
symptoms of these patients. This finding is 
implicitly consistent with the results obtained 
in the study by Mokhtari et al. [48]. In the 
research carried out by Hoseini [49], 
cognitive-behavioral group therapy was used 
















This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0). 
Downloaded from: www.jemerg.com	 	
RBMS.2018;23(1):e1	
results suggested that the subjects in the 
experimental group compared to the control 
group had a significant reduction in depression 
and an increase in mental health and social 
function. In explaining the insignificance of 
the effect of cognitive-behavioral group 
therapy on the dimensions of role limitation 
due to emotional problems, social function, 
physical pain of MS patients in this study, it 
can be mentioned that since some physical 
symptoms associated with MS disease are 
caused by the destruction of the central 
nervous system structure, it cannot be expected 
that all of the physical symptoms of these 
patients have a psychological origin and 
improve under the influence of psychological 
interventions. MS patients experience repeated 
attacks during their illness and their physical 
condition is not under their control. Besides, 
they experience high levels of anxiety and 
depression [9]. These disorders along with 
other factors can interfere with the 
effectiveness of the treatment. One of the 
possible explanations that can be provided for 
this finding is the short duration of cognitive-
behavioral group therapy, which prevents the 
possible impact of this approach on improved 
dimensions of role limitation due to emotional 
problems, social function and physical pain of 
MS patients. 
Results of the present study also indicated that 
cognitive-behavioral group therapy 
significantly increased hopefulness in patients 
suffering from MS. This finding is consistent 
with the results obtained from the studies by 
Omrani et al. [50], Aqa Baqeri et al. [51] and 
Qara’ Zibaei et al. [52]. The research by 
Omrani et al. [50] on 30 MS patients revealed 
that 12 sessions of cognitive-behavioral group 
intervention have a significant effect on 
enhanced hopefulness in MS patients. In the 
study by Aqa Baqeri et al. [51] in which 
mindfulness-based cognitive group therapy 
was used to increase mental well-being and 
hope in MS patients, the results demonstrated 
that the mean scores of mental well-being and 
hope of the subjects in the experimental group 
significantly increased compared to the control 
group. In another study carried out by Qara’ 
Zibaei et al. [52], it was revealed that 
meaning-centered group therapy has a 
significant impact on reduced perceived stress 
and increased life expectancy in MS patients. 
Hence, it seems that both meaning-centered 
therapy and cognitive-behavioral therapy on a 
group basis can be helpful for MS patients. 
According to the findings achieved by Rasouli 
et al. [21], given that enhanced hopefulness 
has a direct impact on improved quality of life 
in MS patients, it seems that teaching 
cognitive components such as cognitive 
restructuring, re-structuring of negative 
emotions, problem-solving training and the 
use of efficient coping strategies, positive 
mental imagery and psychological relaxation 
can decrease depression and anxiety and thus 
increase hopefulness and quality of life in MS 
patients. 
Overall, results of the present study indicate 
the effectiveness of cognitive-behavioral 
group therapy in quality of life and hope 
among MS patients. However, this research 
was subject to certain limitations. Use of the 
available sampling method and the small 
number of subjects will limit the 
generalizability of the results. Moreover, it is 
not clear that the results remain stable over 
time due to the lack of follow-ups. Performing 
the research on wider samples and following 
the therapeutic effects can help to generalize 
the results and confirm the stability of findings 
over time. Further, considering the importance 
of hope and quality of life in different areas of 
life and their key role in mental health, it is 
suggested that in multi-group research 
projects, results of cognitive-behavioral group 
therapy be compared with third-wave therapies 
such as metacognition and treatment based on 
commitment and acceptance or combined 
approaches be used in treatment. 
Conclusion 
Based on the results of the present study, 
cognitive-behavioral group therapy can lead to 
enhanced quality of life and hope among MS 
patients. Patients with MS should reconsider 
their life programs and face recurrent disease 
relapses and lack of autonomy which cause 
frustration and worry. Group cognitive-
behavioral approach leads to improved quality 
of life, increased hope and activation of 
patients by helping the patient share his 
problems and receive effective exposure 
strategies from the group members, 
challenging negative thoughts and idealistic 
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and behavioral strategies. Thus, this low-cost 
and short-term treatment can be applied in all 
centers for the protection of MS patients. 
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